Τετάρτη 2 Μαΐου 2018

Response to Bevacizumab for the treatment of Rendu-Osler disease-A note of caution.

http:--media.wiley.com-assets-7315-19-Wi Related Articles

Response to Bevacizumab for the treatment of Rendu-Osler disease-A note of caution.

Liver Int. 2017 06;37(6):928

Authors: Dupuis-Girod S, Buscarini E

PMID: 28544692 [PubMed - indexed for MEDLINE]



https://ift.tt/2KwnYzh

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου